All-oral, DAA options for HCV effective and well tolerated in patients with decompensated cirrhosis
Interim data presented today at The International Liver Congress 2015 from the HCV-TARGET study show that all-oral, direct-acting antiviral therapy for hepatitis C (HCV) is well tolerated and highly effective in patients ...
Apr 23, 2015
0
2